Published in AIDS on June 26, 2006
What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect (2010) 1.92
Prevention of mother-to-child transmission of human immunodeficiency virus among pregnant women using injecting drugs in Ukraine, 2000-10. Addiction (2011) 1.50
Progress in prevention of mother-to-child transmission of HIV infection in Ukraine: results from a birth cohort study. BMC Infect Dis (2009) 1.11
Use of antiretrovirals during pregnancy and breastfeeding in low-income and middle-income countries. Curr Opin HIV AIDS (2010) 1.09
Prevalence of sexually transmitted infections in HIV-1 infected pregnant women in Europe. Eur J Epidemiol (2007) 0.99
Factors associated with HIV RNA levels in pregnant women on non-suppressive highly active antiretroviral therapy at conception. Antivir Ther (2010) 0.94
Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009. J Acquir Immune Defic Syndr (2011) 0.94
Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe. Antivir Ther (2011) 0.92
Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA. BMC Infect Dis (2007) 0.89
Treatment and disease progression in a birth cohort of vertically HIV-1 infected children in Ukraine. BMC Pediatr (2010) 0.88
Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe. HIV Med (2010) 0.87
Mother-to-child transmission risk is increased among HIV-infected pregnant women in Ukraine with serological test results positive for syphilis. Clin Infect Dis (2008) 0.87
Use of neonatal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV is decreasing in Western Europe. Clin Infect Dis (2009) 0.86
Factors associated with abandonment of infants born to HIV-positive women: results from a Ukrainian birth cohort. AIDS Care (2010) 0.83
Previous reproductive history and post-natal family planning among HIV-infected women in Ukraine. Hum Reprod (2010) 0.81
Antiretroviral therapy, pregnancy, and birth defects: a discussion on the updated data. HIV AIDS (Auckl) (2013) 0.80
Role of the placenta in adverse perinatal outcomes among HIV-1 seropositive women. J Nippon Med Sch (2013) 0.79
HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014. PLoS One (2015) 0.77
Update on HIV in Western Europe. Curr HIV/AIDS Rep (2014) 0.77
Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis (2005) 5.17
Risk factors for mother-to-child transmission of HIV-1. Lancet (1992) 3.76
Fluctuations in symptoms in human immunodeficiency virus-infected children: the first 10 years of life. Pediatrics (2001) 2.54
Combination antiretroviral therapy and duration of pregnancy. AIDS (2000) 2.39
Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. Clin Infect Dis (2007) 1.88
Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. J Acquir Immune Defic Syndr (2003) 1.68
Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome--a European Collaborative Study. J Clin Endocrinol Metab (2004) 1.61
CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation? J Infect Dis (2006) 1.46
Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. Pediatrics (2003) 1.45
Management of vertically HIV-infected children in Europe. Acta Paediatr (2003) 1.39
Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women? J Acquir Immune Defic Syndr (2005) 1.32
Age-related standards for total lymphocyte, CD4+ and CD8+ T cell counts in children born in Europe. Pediatr Infect Dis J (2005) 1.23
Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers. AIDS (2004) 1.21
Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers. AIDS (2005) 1.08
Older children and adolescents surviving with vertically acquired HIV infection. J Acquir Immune Defic Syndr (2002) 1.07
Increasing likelihood of further live births in HIV-infected women in recent years. BJOG (2005) 1.05
Level and pattern of HIV-1-RNA viral load over age: differences between girls and boys? AIDS (2002) 1.03
Within and between race differences in lymphocyte, CD4+, CD8+ and neutrophil levels in HIV-uninfected children with or without HIV exposure in Europe and Uganda. Ann Trop Paediatr (2006) 1.03
Are there gender and race differences in cellular immunity patterns over age in infected and uninfected children born to HIV-infected women? J Acquir Immune Defic Syndr (2003) 1.00
Does exposure to antiretroviral therapy affect growth in the first 18 months of life in uninfected children born to HIV-infected women? J Acquir Immune Defic Syndr (2005) 0.96
Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009. J Acquir Immune Defic Syndr (2011) 0.94
Pregnancy-related changes in the longer-term management of HIV-infected women in Europe. Eur J Obstet Gynecol Reprod Biol (2003) 0.89
Are girls more at risk of intrauterine-acquired HIV infection than boys? AIDS (2004) 0.89
Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe. HIV Med (2010) 0.87
Use of neonatal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV is decreasing in Western Europe. Clin Infect Dis (2009) 0.86
Levels and patterns of HIV RNA viral load in untreated pregnant women. Int J Infect Dis (2008) 0.81
Gender and race do not alter early-life determinants of clinical disease progression in HIV-1 vertically infected children. AIDS (2004) 0.77